Inventor · disambiguated record
Joachim Zettler
Also filed as: ZETTLER JOACHIM
13 granted patents·13 pending applications·47 citations·filing 2012–2025
90Inventor score
Files withASCENDIS PHARMA BONE DISEASES AS16ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S3ASCENDIS PHARMA AS2HERSEL ULRICH2ASCENDIS PHARMA OSTEOARTHRITIS DIV A/S1
Top patents by PatentIndex Score
26 records- 0196US11890326B2Controlled-release PTH compoundASCENDIS PHARMA BONE DISEASES AS·Filed 2022·Granted Feb 6, 2024·5 cites·11 claims
- 0296US11793861B2PTH prodrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2022·Granted Oct 24, 2023·5 cites·15 claims
- 0395US11918628B2Controlled-release PTH compoundASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Granted Mar 5, 2024·4 cites·9 claims
- 0495US11857603B2PTH compounds with low peak-to-trough ratiosASCENDIS PHARMA BONE DISEASES AS·Filed 2022·Granted Jan 2, 2024·5 cites·12 claims
- 0592US11759504B2PTH compounds with low peak-to-trough ratiosASCENDIS PHARMA BONE DISEASES AS·Filed 2017·Granted Sep 19, 2023·6 cites·12 claims
- 0690US12133883B2Polymeric hGH prodrugsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2020·Granted Nov 5, 2024·2 cites·21 claims
- 0789US10799563B2Polymeric hGH prodrugsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2015·Granted Oct 13, 2020·10 cites·21 claims
- 0889US2025268988A1PTH ProdrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2024·Application pending·0 cites
- 0987US12295989B2Controlled-release PTH compoundASCENDIS PHARMA BONE DISEASES AS·Filed 2024·Granted May 13, 2025·0 cites·5 claims
- 1087US12214020B2PTH prodrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Granted Feb 4, 2025·0 cites·9 claims
- 1186US2025032587A1Novel Polymeric hGH ProdrugsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2024·Application pending·0 cites
- 1281US2023321198A1Dosage Regimen for a Controlled-Release PTH CompoundASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Application pending·0 cites
- 1380US2024173385A1PTH Compounds with Low Peak-To-Trough RatiosASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Application pending·0 cites
- 1479US9872864B2Sustained release composition of prostacyclinSPROGØE KENNETT·Filed 2012·Granted Jan 23, 2018·6 cites·13 claims
- 1577US10729778B2Carrier-linked treprostinil prodrugsHERSEL ULRICH·Filed 2017·Granted Aug 4, 2020·1 cites·24 claims
- 1677US2022008516A1PTH ProdrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2021·Application pending·0 cites
- 1777US2025302924A1Controlled-Release PTH CompoundASCENDIS PHARMA BONE DISEASES AS·Filed 2025·Application pending·0 cites
- 1875US9561287B2Carrier-linked treprostinil prodrugsHERSEL ULRICH·Filed 2012·Granted Feb 7, 2017·3 cites·28 claims
- 1971US2020360487A1Pth prodrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2020·Application pending·0 cites
- 2071US2020376089A1Pth prodrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2020·Application pending·0 cites
- 2161US2020276276A1PTH ProdrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2017·Application pending·0 cites
- 2251US2016089446A1Modified HydrogelsASCENDIS PHARMA AS·Filed 2014·Application pending·0 cites
- 2350US2018042996A1Hydrogel-Linked IL-1ra ProdrugASCENDIS PHARMA OSTEOARTHRITIS DIV A/S·Filed 2014·Application pending·0 cites
- 2449US2019262426A1Hydrogel-Linked IL-1ra ProdrugASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
- 2548US12453778B2Incremental dose finding in controlled-release PTH compoundsASCENDIS PHARMA BONE DISEASES AS·Filed 2017·Granted Oct 28, 2025·0 cites·8 claims
- 2643US2016296600A1Relaxin ProdrugsASCENDIS PHARMA RELAXIN DIV AS·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →